Briefing From The Editor -- NOC Stock

Large-cap Technology company Northrop Grumman has moved 0.9% so far today on a volume of 220,581, compared to its average of 1,117,132. In contrast, the S&P 500 index moved -0.0%.

Northrop Grumman trades -8.84% away from its average analyst target price of $517.89 per share. The 18 analysts following the stock have set target prices ranging from $367.0 to $655.0, and on average have given Northrop Grumman a rating of buy.

Anyone interested in buying NOC should be aware of the facts below:

  • Northrop Grumman's current price is 92.2% above its Graham number of $245.62, which implies that at its current valuation it does not offer a margin of safety

  • Northrop Grumman has moved 1.4% over the last year, and the S&P 500 logged a change of -8.5%

  • Based on its trailing earnings per share of 31.49, Northrop Grumman has a trailing 12 month Price to Earnings (P/E) ratio of 15.0 while the S&P 500 average is 15.97

  • NOC has a forward P/E ratio of 19.3 based on its forward 12 month price to earnings (EPS) of $24.45 per share

  • The company has a price to earnings growth (PEG) ratio of 7.09 — a number near or below 1 signifying that Northrop Grumman is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 4.7 compared to its sector average of 6.23

  • Northrop Grumman Corporation operates as an aerospace and defense company worldwide.

  • Based in Falls Church, the company has 95,000 full time employees and a market cap of $72,257,085,440. Northrop Grumman currently returns an annual dividend yield of 1.4%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.